Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

629 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Progress in the treatment of acute myeloid leukemia.
Ravandi F, Burnett AK, Agura ED, Kantarjian HM. Ravandi F, et al. Cancer. 2007 Nov 1;110(9):1900-10. doi: 10.1002/cncr.23000. Cancer. 2007. PMID: 17786921 Review.
Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significance.
Ravandi F, Cortes J, Albitar M, Arlinghaus R, Qiang Guo J, Talpaz M, Kantarjian HM. Ravandi F, et al. Br J Haematol. 1999 Dec;107(3):581-6. doi: 10.1046/j.1365-2141.1999.01736.x. Br J Haematol. 1999. PMID: 10583263
A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
Ravandi F, Estrov Z, Kurzrock R, Breitmeyer JB, Maschek BJ, Talpaz M. Ravandi F, et al. Clin Cancer Res. 1999 Dec;5(12):3990-8. Clin Cancer Res. 1999. PMID: 10632330 Clinical Trial.
Phase II trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer.
Ravandi F, Rytting ME, Osmon C, Braud EL, Roach RW, Edwards K, Winn R, Abbruzzese JL, Pazdur R. Ravandi F, et al. Anticancer Drugs. 1999 Jul;10(6):519-24. doi: 10.1097/00001813-199907000-00002. Anticancer Drugs. 1999. PMID: 10885898 Clinical Trial.
Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia.
Ravandi F, Hayes K, Cortes J, Albitar M, Glassman A, Talpaz M, Kantarjian HM. Ravandi F, et al. Cancer. 2001 May 1;91(9):1704-8. Cancer. 2001. PMID: 11335894 No abstract available.
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ, Thomas D, Cortes J, Andreeff M, Estrov Z, Rios MB, Albitar M. Ravandi F, et al. Cancer. 2001 Jun 1;91(11):1964-72. doi: 10.1002/1097-0142(20010601)91:11<1964::aid-cncr1221>3.0.co;2-b. Cancer. 2001. PMID: 11391574
Decitabine with allogeneic peripheral blood stem cell transplantation in the therapy of leukemia relapse following a prior transplant: results of a phase I study.
Ravandi F, Kantarjian H, Cohen A, Davis M, O'Brien S, Anderlini P, Andersson B, Claxton D, Donato M, Gajewski J, Khouri I, Korbling M, Ueno N, deVos D, Champlin R, Giralt S. Ravandi F, et al. Bone Marrow Transplant. 2001 Jun;27(12):1221-5. doi: 10.1038/sj.bmt.1703028. Bone Marrow Transplant. 2001. PMID: 11548839 Clinical Trial.
Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignancies.
Ravandi F, Talpaz M, Estrov Z. Ravandi F, et al. Clin Cancer Res. 2003 Feb;9(2):535-50. Clin Cancer Res. 2003. PMID: 12576416 Review.
Long-term follow-up of a phase I study of high-dose decitabine, busulfan, and cyclophosphamide plus allogeneic transplantation for the treatment of patients with leukemias.
de Lima M, Ravandi F, Shahjahan M, Andersson B, Couriel D, Donato M, Khouri I, Gajewski J, van Besien K, Champlin R, Giralt S, Kantarjian H. de Lima M, et al. Among authors: ravandi f. Cancer. 2003 Mar 1;97(5):1242-7. doi: 10.1002/cncr.11184. Cancer. 2003. PMID: 12599231 Clinical Trial.
Comprehensive analysis of CBFbeta-MYH11 fusion transcripts in acute myeloid leukemia by RT-PCR analysis.
Kadkol SS, Bruno A, Dodge C, Lindgren V, Ravandi F. Kadkol SS, et al. Among authors: ravandi f. J Mol Diagn. 2004 Feb;6(1):22-7. doi: 10.1016/s1525-1578(10)60487-4. J Mol Diagn. 2004. PMID: 14736823 Free PMC article.
629 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback